<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wright M</submitter><funding>NHSI</funding><pagination>104-109</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10935515</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(2)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Liver disease deaths are rising, but specialist palliative care services for hepatology are limited. Expansion across the NHS is required.&lt;h4>Methods&lt;/h4>We surveyed clinicians, patients and carers to design an 'ideal' service. Using standard NHS tariffs, we calculated the cost of this service. In hospitals where specialist palliative care was available for liver disease, patient-level costs and bed utilisation in last year of life (LYOL) were compared between those seen by specialist palliative care before death and those not.&lt;h4>Results&lt;/h4>The 'ideal' service was described. Costs were calculated as whole time equivalent for a minimal service, which could be scaled up. From a hospital with an existing service, patients seen by specialist palliative care had associate</pubmed_abstract><journal>Frontline gastroenterology</journal><pubmed_title>Developing a generic business case for an advanced chronic liver disease support service.</pubmed_title><pmcid>PMC10935515</pmcid><funding_grant_id>N/A</funding_grant_id><pubmed_authors>Verma S</pubmed_authors><pubmed_authors>Prentice W</pubmed_authors><pubmed_authors>Willmore S</pubmed_authors><pubmed_authors>Sahota H</pubmed_authors><pubmed_authors>Stockley AJ</pubmed_authors><pubmed_authors>Wright M</pubmed_authors><pubmed_authors>Hudson B</pubmed_authors><pubmed_authors>Finlay F</pubmed_authors><pubmed_authors>Omasta-Martin A</pubmed_authors><pubmed_authors>Verne J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Developing a generic business case for an advanced chronic liver disease support service.</name><description>&lt;h4>Introduction&lt;/h4>Liver disease deaths are rising, but specialist palliative care services for hepatology are limited. Expansion across the NHS is required.&lt;h4>Methods&lt;/h4>We surveyed clinicians, patients and carers to design an 'ideal' service. Using standard NHS tariffs, we calculated the cost of this service. In hospitals where specialist palliative care was available for liver disease, patient-level costs and bed utilisation in last year of life (LYOL) were compared between those seen by specialist palliative care before death and those not.&lt;h4>Results&lt;/h4>The 'ideal' service was described. Costs were calculated as whole time equivalent for a minimal service, which could be scaled up. From a hospital with an existing service, patients seen by specialist palliative care had associate</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-07-15T00:39:38.541Z</modification><creation>2026-06-27T03:05:36.305Z</creation></dates><accession>S-EPMC10935515</accession><cross_references><pubmed>38486664</pubmed><doi>10.1136/flgastro-2023-102530</doi></cross_references></HashMap>